Journals / Turkish Journal of Surgery / 2022 / Cilt: 38 - Sayı: 2

Intraoperative and postoperative impact of pretransplantation transjugular intrahepatic portosystemic shunts in orthotopic liver transplantations: A systematic review and meta-analysis

Ortotopik karaciğer transplantasyonunda transplantasyon öncesi transjuguler intrahepatik portosistemik şantın intraoperatif ve postoperatif etkileri: Sistematik bir derleme ve meta analiz

Pages
121–133
Publication Date
2022-11-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our study found TIPS can be safely employed without having detrimental impacts on OLT outcomes, furthermore, these findings also suggest TIPS does not increase bleeding or complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Orthotopic liver transplantation (OLT) remains the definitive treatment for patients afflicted with end-stage liver disease (ESLD).
📊
Key Findings & Data:Data were analyzed using Review Manager 5.3.
💡
Conclusion & Impact:Conclusion: Our study found TIPS can be safely employed without having detrimental impacts on OLT outcomes, furthermore, these findings also suggest TIPS does not increase bleeding or complications.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Orthotopic liver transplantation (OLT) remains the definitive treatment for patients afflicted with end-stage liver disease (ESLD). Transjugular intrahepatic portosystemic shunts (TIPS) have been adapted as a bridge to transplantation, allowing partial normalization of portal pressure and associated symptom improvement. Conflicting evidence exists on TIPS’ impact on operative procedures. This study aimed to analyze available evidence on patients who underwent OLT with prior TIPS compared to OLT alone with the intent to determine TIPS’ impact on surgical outcomes. Material and Methods: Following PRISMA guidelines, a systematic review was conducted, identifying studies comparing TIPS + OLT versus OLT alone in patients with ESLD. Data were analyzed using Review Manager 5.3. Results: Thirteen studies were included. Operative time, packed red blood cells transfusions, intensive care unit admission, length of stay, dialysis, serum creatinine levels, ascites, vascular complications, bleeding revisions, reintervention, and other complications rates were similar between both groups. Fresh frozen plasma transfusion -2.88 units (-5.42, -0.35; p= 0.03), was lower in the TIPS + OLT group. Conclusion: Our study found TIPS can be safely employed without having detrimental impacts on OLT outcomes, furthermore, these findings also suggest TIPS does not increase bleeding or complications.

Özet

Giriş ve Amaç: Ortotopik karaciğer transplantasyonu (OKT) son evre karaciğer hastalığında (SEKH) kesin tedavi yöntemidir. Transjuguler intrahepatik portosistemik şantlar (TIPS), transplantasyona bir köprü olarak uyarlanmıştır ve portal basıncın parsiyel normalleşmesine ve ilişkili semptomların iyileşmesine sebep olur. Operatif prosedürlerde TIPS’in etkisi ile ilgili çelişkili kanıtlar vardır. Bu çalışmanın amacı, TIPS’ın cerrahi sonuçlara etkisini belirlemek adına önce TIPS sonra OKT geçiren ve sadece OKT geçiren hastaların verileri analiz etmekti. Gereç ve Yöntem: SEKH sahip hastalarda TIPS + OKT ve sadece OKT uygulanan hastaların bulunduğu çalışmalar belirlenip PRISMA kılavuz ilkelerini takip ederek bir sistematik değerlendirme uygulandı. Veriler Data Review Manager 5,3 kullanılarak analiz edildi. Bulgular: On üç çalışma dahil edildi. Her iki grupta da operatif süre, alyuvar transfüzyonu, yoğun bakımda kalış süresi, hastanede kalış süresi, diyaliz, serum kreatinin seviyeleri, assit, vasküler komplikasyonlar, kanama revizyonları, tekrar müdahale ve diğer komplikasyonlar benzerdi. Taze donmuş plazma transfüzyonu -2,88 ünite (-5,42, -0,35; p= 0,03) TIPS + OKT grubunda daha düşüktü. Sonuç: Çalışmamızda, TIPS’nin OKT sonuçlarına zararlı herhangi bir etkisi olmadan güvenle uygulanabileceğini ve bundan ötürü de TIPS’nin kanamayı veya komplikasyonları artırmadığını bulduk

🔖

Cite This Article

GONZALEJ, D. E. H., GARCIA, E. T., GARZA, G. S., MEDRANO, A. R., GUTIERREZ, L. C. B., LEON, S. U. V. D., CONDE, M. A. E., CARRILO, F. E. H., VILLALBA, E. F. (2022). Intraoperative and postoperative impact of pretransplantation transjugular intrahepatic portosystemic shunts in orthotopic liver transplantations: A systematic review and meta-analysis. Turkish Journal of Surgery, Cilt: 38 - Sayı: 2, 121–133. https://ajindex.com/articles/614221

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. O’Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology 2008
  2. https://doi.org/10.1053/j.gastro. 2008.02.028 2. Varma V, Mehta N, Kumaran V, Nundy S. Indications and contraindications for liver transplantation. Int J Hepatol 2011: 1-9. https://doi. org/10.4061/2011/121862 3. Contreras AG, McCormack L, Andraus W, de Souza M Fernandes E, Contreras AG, McCormack L, et al. Current status of liver transplantation in Latin America. Int J Surg 2020
  3. https://doi. org/10.1016/j.ijsu.2020.03.039 4. Jadlowiec CC, Timucin, Taner. Liver transplantation: Current status and challenges. World J Gastroenterol 2016
  4. https://doi. org/10.3748/wjg.v22.i18.4438 5. Alferink LJM, Oey RC, Hansen BE, Polak G, van Buuren HR, de Man RA, et al. The impact of infections on delisting patients from the liver transplantation waiting list. Transpl Int 2017
  5. https://doi. org/10.1111/tri.12965 6. Fink MA, Berry SR, Gow PJ, Angus PW, Wang B-Z, Muralidharan V, et al. Risk factors for liver transplantation waiting list mortality. J Gastroenterol Hepatol 2007
  6. https://doi.org/10.1111/j.1440- 1746.2006.04422.x 7. Hung ML, Lee EW. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Clin Liver Dis 2019
  7. https://doi.org/10.1016/j.cld.2019.07.004 8. Tan HK, James PD, Sniderman KW, Wong F. Longterm clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion. J Gastroenterol Hepatol 2015
  8. https://doi.org/10.1111/jgh.12725 9. Vizzutti F, Schepis F, Arena U, Fanelli F, Gitto S, Aspite S, et al.Transjugular intrahepatic portosystemic shunt (TIPS): Current indications and strategies to improve the outcomes. Intern Emerg Med 2020
  9. https://doi.org/10.1007/s11739-019-02252-8 10. Pateria P, Jeffrey GP, Garas G, Tibballs J, Ferguson J, Delriviere L, et al. transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western Australia. J Med Imaging Radiat Oncol 2017
  10. https://doi.org/10.1111/1754-9485.12563 11. Sellers CM, Nezami N, Schilsky ML, Kim HS. Transjugular intrahepatic portosystemic shunt as a bridge to liver transplant: Current state and future directions. Transplant Rev 2019
  11. https://doi. org/10.1016/j.trre.2018.10.004 12. Barbier L, Hardwigsen J, Borentain